Osama Karim Abed
YOU?
Author Swipe
View article: Letter: be careful of gastrointestinal <scp>CMV</scp> infection in adverse event from <scp>ICIs</scp> therapy in solid tumours—Authors' reply
Letter: be careful of gastrointestinal <span>CMV</span> infection in adverse event from <span>ICIs</span> therapy in solid tumours—Authors' reply Open
LINKED CONTENT This article is linked to Dahl et al papers. To view these articles, visit https://doi.org/10.1111/apt.17201 and https://doi.org/10.1111/apt.17416
View article: Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis Open
Summary Background Cancer patients treated with immune check point inhibitors are at risk of developing severe colitis. However, the efficacy and safety of treatment of severe colitis is poorly understood. Aims To explore the safety and ef…
View article: Polymorphisms in the <scp>NF</scp>kB, <scp>TNF</scp>‐alpha, <scp>IL</scp>‐1beta, and <scp>IL</scp>‐18 pathways are associated with response to anti‐<scp>TNF</scp> therapy in Danish patients with inflammatory bowel disease
Polymorphisms in the <span>NF</span>kB, <span>TNF</span>‐alpha, <span>IL</span>‐1beta, and <span>IL</span>‐18 pathways are associated with response to anti‐<span>TNF</span> therapy in Danish patients with inflammatory bowel disease Open
Summary Background Anti‐tumor necrosis factor‐α ( TNF ‐α) is used for the treatment of severe cases of IBD , including Crohn's disease ( CD ) and ulcerative colitis ( UC ). However, one‐third of the patients do not respond to the treatment…